APSR2026-491

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-045
P100
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220225-46904-Management of Reactivated Pulmonary Tuberculoma in an Immunosuppressed Spondyloarthritis Patient_434034.pdf
Format: PDF Only
06. Tuberculosis
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Abraham Bayu Theodoron Situmorang * Universitas Airlangga Pulmonology and Respiratory Medicine, Faculty of Medicine Surabaya Indonesia
Daniel Maranatha - Universitas Airlangga Pulmonology and Respiratory Medicine Surabaya Indonesia
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Abraham Bayu Theodoron
Situmorang
abrahambayuu@gmail.com
+6282111008696
31-40
Indonesia
Case Report
Management of reactivated pulmonary tuberculoma in an immunosuppressed spondyloarthritis patient
Maximum 25 words
Abstract Content
 
 
 
 
Pulmonary Tuberculoma represents 6-9% of pulmonary tuberculosis (TB) cases, forming caseous granulomas encapsulated by fibrosis with reactivation potential under immunosuppression due to long-term corticosteroids. TB reactivation risks rise, necessitating invasive diagnostics like video-assisted thoracoscopic surgery (VATS) for granulomatous lesions often mimicking malignancy on imaging and requiring invasive diagnosis.
A 28-year-old female with spondyloarthritis on long-term sulfasalazine and methylprednisolone presented with 4-month dyspnea and 2-kg weight loss, with a prior history of treated pulmonary tuberculosis (2019). High-resolution computed tomography in 2024 revealed a solitary pulmonary nodule with perinodular fibrosis in the right lung upper lobe. The patient underwent VATS wedge resection for definitive diagnosis. Histopathological examination revealed granulomatous inflammation with necrosis, and tissue GeneXpert detected rifampicin-sensitive Mycobacterium tuberculosis. Standard Anti-tuberculosis drugs caused hepatotoxicity during the first month of treatment, required regimen modification followed by successful reintroduction. Treatment was continued with rifampicin, isoniazid, and ethambutol for 9 months. At 6-month follow-up, thoracic CT scan showed no residual nodules, with clinical improvement after treatment.
Tuberculomas arise from primary Ghon complexes that stabilize as avascular caseous nodules >2cm, typically in upper lobes, remaining dormant until immunosuppression disrupts granuloma integrity. Immunosuppression due to corticosteroids significantly contributes to tuberculosis reactivation, emphasizing the need for vigilant evaluation in high-risk patients with prior tuberculosis history, when corticosteroids suppress cell-mediated immunity essential for granuloma containment. VATS enabled complete excision, providing definitive diagnosis when imaging and cultures were inconclusive. This approach not only excluded malignancy but also facilitated timely initiation of targeted anti-tuberculosis therapy, especially in patients with prior tuberculosis and spondyloarthritis.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Pulmonary tuberculoma, Immunosuppression, Video assisted thoracoscopic surgery
maximum 3 keywords and no abbreviations, separated by commas
None
252